HIV.gov is blogging and "Facebook Live-ing" from IAS 2019 in Mexico City, bringing you, so far, Ending the Epidemic, HIV research updates, and vaginal rings for HIV prevention. Beyond these highlights, try scanning the online programme, which has a search feature and multiple portals, like sessions, abstracts (oral, poster, discussion), and Roadmaps (organized by topics, like co-morbidities and co-infections).
Here are several session abstracts we found of note. Scan and search the online programme for much more.
- HIV infection after stopping PrEP in a U.S. safety-net integrated health system: A mixed methods study (TUPEC428), an abstract from UCSF, found that "HIV incidence after stopping PrEP was eight-fold higher than while on PrEP."
- The cost-effectiveness of evidence-based HIV testing interventions in six US cities (TUPED710) concluded: "Evidence-based HIV testing strategies were cost saving across all six cities, regardless of current testing rates."
- The hepatitis C treatment cascade in the era of direct-acting antivirals (DAAs), and barriers to DAA treatment initiation, among US men and women with and without HIV (TUPDB0105) found, in several study cohorts, that "people with HIV were more likely to receive treatment for HCV and attain SVR [sustained virologic response]" as compared to HIV-negative individuals in the cohorts and that "HIV-related care may facilitate navigation of HCV treatment barriers."